causal

Consumers Will Accept Compounded Risk at Lower Price

Patients who cannot afford $400 to $500 a month will still take compounded GLP-1s that have had no clinical trials, because they value the benefit enough to accept unknown manufacturing and safety risks at about $200 to $250 a month.

causalpending

Speaker

Alex Karnal

Evidence Quote

“they could afford $200, $250 a month.”

Source

Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]— Invest Like the Best
Created: 11/14/2026, 4:24:39 AM

Your notes

Loading notes...